These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 27111579)

  • 1. Comparison of DRY and WET vaginal swabs with cervical specimens in Roche Cobas 4800 HPV and Abbott RealTime High Risk HPV tests.
    Jun JK; Lim MC; Hwang SH; Shin HY; Hwang NR; Kim YJ; Yoo CW; Lee DO; Joo J; Park SY; Lee DH
    J Clin Virol; 2016 Jun; 79():80-84. PubMed ID: 27111579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pilot study to compare dry cervical sample collection with standard practice of wet cervical samples for human papillomavirus testing.
    Sultana F; Gertig DM; Wrede CD; English DR; Simpson JA; Drennan KT; Brotherton JM; Phillips G; Heley S; Castle PE; Saville M
    J Clin Virol; 2015 Aug; 69():210-3. PubMed ID: 26209409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the Abbott RealTime High Risk HPV test and the Roche cobas 4800 HPV test using urine samples.
    Lim MC; Lee DH; Hwang SH; Hwang NR; Lee B; Shin HY; Jun JK; Yoo CW; Lee DO; Seo SS; Park SY; Joo J
    J Virol Methods; 2017 May; 243():74-79. PubMed ID: 28161277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy of self-collected vaginal dry swabs using the Xpert human papillomavirus assay.
    Catarino R; Vassilakos P; Bilancioni A; Bougel S; Boukrid M; Meyer-Hamme U; Petignat P
    PLoS One; 2017; 12(7):e0181905. PubMed ID: 28750015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability Study of Cervical Specimens Collected by Swab and Stored Dry Followed by Human Papillomavirus DNA Detection Using the cobas 4800 Test.
    Lin CQ; Zeng X; Cui JF; Liao GD; Wu ZN; Gao QQ; Zhang X; Yu XZ; Chen W; Xi MR; Qiao YL
    J Clin Microbiol; 2017 Feb; 55(2):568-573. PubMed ID: 27927922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized comparison of vaginal self-sampling by standard vs. dry swabs for human papillomavirus testing.
    Eperon I; Vassilakos P; Navarria I; Menoud PA; Gauthier A; Pache JC; Boulvain M; Untiet S; Petignat P
    BMC Cancer; 2013 Jul; 13():353. PubMed ID: 23875668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of urine, self-collected vaginal swab, and cervical swab samples for detecting human papillomavirus (HPV) with Roche Cobas HPV, Anyplex II HPV, and RealTime HR-S HPV assay.
    Cho HW; Ouh YT; Hong JH; Min KJ; So KA; Kim TJ; Paik ES; Lee JW; Moon JH; Lee JK
    J Virol Methods; 2019 Jul; 269():77-82. PubMed ID: 30998958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accuracy of dry vaginal self-sampling for detecting high-risk human papillomavirus infection in cervical cancer screening: a cross-sectional study.
    Haguenoer K; Giraudeau B; Gaudy-Graffin C; de Pinieux I; Dubois F; Trignol-Viguier N; Viguier J; Marret H; Goudeau A
    Gynecol Oncol; 2014 Aug; 134(2):302-8. PubMed ID: 24905772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An evaluation of clinical performance of FTA cards for HPV 16/18 detection using cobas 4800 HPV Test compared to dry swab and liquid medium.
    Dong L; Lin C; Li L; Wang M; Cui J; Feng R; Liu B; Wu Z; Lian J; Liao G; Chen W; Qiao Y
    J Clin Virol; 2017 Sep; 94():67-71. PubMed ID: 28763729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Test performance and acceptability of self- versus provider-collected swabs for high-risk HPV DNA testing in female-to-male trans masculine patients.
    Reisner SL; Deutsch MB; Peitzmeier SM; White Hughto JM; Cavanaugh TP; Pardee DJ; McLean SA; Panther LA; Gelman M; Mimiaga MJ; Potter JE
    PLoS One; 2018; 13(3):e0190172. PubMed ID: 29538411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized Comparison of Two Vaginal Self-Sampling Methods for Human Papillomavirus Detection: Dry Swab versus FTA Cartridge.
    Catarino R; Vassilakos P; Bilancioni A; Vanden Eynde M; Meyer-Hamme U; Menoud PA; Guerry F; Petignat P
    PLoS One; 2015; 10(12):e0143644. PubMed ID: 26630353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of self-collected vaginal specimens for the detection of high-risk human papillomavirus infection and the prediction of high-grade cervical intraepithelial lesions in a high-burden, low-resource setting.
    Toliman PJ; Kaldor JM; Badman SG; Phillips S; Tan G; Brotherton JML; Saville M; Vallely AJ; Tabrizi SN
    Clin Microbiol Infect; 2019 Apr; 25(4):496-503. PubMed ID: 29906593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective pilot evaluation of vaginal and urine self-sampling for the Roche cobas 4800 HPV test for cervical cancer screening.
    Hwang SH; Shin HY; Lee DO; Sung NY; Lee B; Lee DH; Jun JK
    Sci Rep; 2018 Jun; 8(1):9015. PubMed ID: 29899531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analytical performance of HPV assays on vaginal self-collected vs practitioner-collected cervical samples: the SCoPE study.
    Saville M; Hawkes D; Keung M; Ip E; Silvers J; Sultana F; Malloy MJ; Velentzis LS; Canfel L K; Wrede CD; Brotherton J
    J Clin Virol; 2020 Jun; 127():104375. PubMed ID: 32361328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VALHUDES: A protocol for validation of human papillomavirus assays and collection devices for HPV testing on self-samples and urine samples.
    Arbyn M; Peeters E; Benoy I; Vanden Broeck D; Bogers J; De Sutter P; Donders G; Tjalma W; Weyers S; Cuschieri K; Poljak M; Bonde J; Cocuzza C; Zhao FH; Van Keer S; Vorsters A
    J Clin Virol; 2018 Oct; 107():52-56. PubMed ID: 30195193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Head-to-Head Analytical Comparison of Cobas 4800 HPV, PapilloCheck HPV Screening, and LMNX Genotyping Kit HPV GP for Detection of Human Papillomavirus DNA in Cervical and Cervicovaginal Swabs.
    Jaworek H; Koudelakova V; Drabek J; Vrbkova J; Zborilova B; Oborna I; Brezinova J; Marek R; Huml K; Vanek P; Hajduch M
    J Mol Diagn; 2018 Nov; 20(6):849-858. PubMed ID: 30165205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Pre-Analytical Variables for Human Papillomavirus Primary Screening from Self-Collected Vaginal Swabs.
    Qi M; Naranjo AR; Duque AJ; Lorey TS; Schapiro JM; Suh-Burgmann BJ; Rummel M; Salipante SJ; Wentzensen N; Greene DN
    J Mol Diagn; 2024 Jun; 26(6):487-497. PubMed ID: 38494078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Performance of the RealTi
    Latsuzbaia A; Vanden Broeck D; Van Keer S; Weyers S; Tjalma WAA; Doyen J; Donders G; De Sutter P; Vorsters A; Peeters E; Arbyn M
    Microbiol Spectr; 2022 Oct; 10(5):e0163122. PubMed ID: 36047900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative evaluation of three commercial systems for detection of high-risk human papillomavirus in cervical and vaginal ThinPrep PreservCyt samples and correlation with biopsy results.
    Binnicker MJ; Pritt BS; Duresko BJ; Espy MJ; Grys TE; Zarka MA; Kerr SE; Henry MR
    J Clin Microbiol; 2014 Oct; 52(10):3763-8. PubMed ID: 25122861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of dry and wet transport of at-home self-collected vaginal swabs for human papillomavirus testing.
    Wolfrum SG; Koutsky LA; Hughes JP; Feng Q; Xi LF; Shen Z; Winer RL
    J Med Microbiol; 2012 Nov; 61(Pt 11):1538-1545. PubMed ID: 22899778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.